ServiceMis à jour le 21 septembre 2026

Drug discovery of type II transmembrane serine protease inhibitors and adhesion GPCR ligands

Professeur à Université de Sherbrooke

Sherbrooke, Canada

Détails

In collaboration with medicinal chemists and molecular pharmacologists we have developed small peptidomimetic inhibitors for type II transmembrane serine proteases and bioluminescence resonance energy transfer assays to discover novel adhesion GPCR ligands involved in cell signaling.

Organisation

Université de Sherbrooke

Établissement postsecondaire (Université, Collège)

Sherbrooke, Canada

Opportunités similaires